KENDRA MILLER: Open Payments
NPI 1306532791 · CANON CITY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 23 payments from 13 companies in 2025. Trend: 2023 $87 · 2024 $245 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $170 |
| PFIZER INC. | 3 | $64 |
| Novo Nordisk Inc | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Edwards Lifesciences Corporation | 2 | $49 |
| Corcept Therapeutics | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| SCILEX PHARMACEUTICALS INC. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: CREON, NURTEC ODT, UBRELVY, CAPLYTA, Ozempic, SAPIEN 3 Ultra RESILIA, Korlym, SHINGRIX.
Industry payments across CO — which companies pay providers there.
